Роль нарушения обмена жирных кислот в развитии дисплипротеинемий
Диссертация
Предполагается, что одной из главных причин развития вышеперечисленных гипертриглицеридемий является нарушение в системе образования и транспорта неэстерифицированных жирных кислот (НЭЖК) в плазме крови. Важную роль в регуляции метаболизма жирных кислот играют липопротеинлипаза (ЛТТЛ) и гормон — чувствительная липаза (ГЧЛ), увеличение активности которых приводит к повышению концентрации жирных… Читать ещё >
Список литературы
- Беляков H.A., Сеидова Г. Б., Чубриева С. Ю. и др. Метаболический синдром у женщин патофизиология и клиника. //СПб: Изд. дом СПбМАПО, 2005. 440с.
- Государственный доклад о состоянии здоровья Российской Федерации в 2004. // Здравоохранение Российской Федерации. 2006. — № 3 — С. З — 23- № 4. — С. 3 — 32- № 5. С. — 3 — 25.
- Демидова Д.В., Ларионова В. И., Волкова М. В. и др. Анализ влияния структуры генов липопротеиновой липазы, аполипопротеинов С III и Е на развитие гиперлипидемии. // Кардиология — 2001. — № 8. — С. 17 -22.
- Денисенко А.Д. Система транспорта липидов в крови. // Актовая речь на заседании Ученого Совета НИИЭМ РАМН / СПб, 1999. 18с.
- Климов А.Н., Никульчева Н. Г. Дислипопротеидемия и ишемическая болезнь сердца. / ред. Е. И. Чазов // М.:Медицина, 1980. 312с.
- Климов А.Н., Гуревич B.C., Никифорова. A.A. и др. Антиоксидантная активность липопротеидов высокой плотности in vivo. // Бюлл.эксп.биол.мед. 1992. — № 114. — С. 40 — 42.
- Климов А.Н., Никульчева Н. Г. Обмен липидов и липопротеидов и его нарушения. // СПб: Питер Ком., 1999. 512 с.
- Мамедов М.Н. Целесообразность применения фибратов для первичной и вторичной профилактики сердечно сосудистых осложнений. / М. Н. Мамедов // Кардиология. — 2006. — № 46. — С.39 — 47.
- Оганов Р.Г. Факторы риска и профилактика сердечно сосудистых заболеваний. // Качество жизни. — 2003. — № 2. — С. Ю — 15.
- Парфенова Н.С. Метаболический синдром. // Российский кардиологический журнал. 1998. — № 2. — С.42 — 48.
- Хечинашвили Г. Г., Никульчева Н. Г. Липопротеидлипаза, печеночная триглицеридная липаза и некоторые другие липолитические ферменты животного организма. // Успехи биол.химии. 1980. — № 21.-С. 163- 184.
- Чазова И.Е., Мычка В. Б. Метаболический синдром. // М.: Медиа Медика, 2008. 324с.
- Шестов Д.Б. Расчет холестерина липопротеидов низкой плотности в миллимолях. // Лаб.дело. 1985. — № 6. — С. 381.
- Aarsland A., Chinkes D., Wolfe R.R. Contributions of de novo synthesis of fatty acids to total VLDL triglyceride secretion during prolonged Ьурещ1усегтаЛ1урегт8иНпе1ша in normal man. // J.Clin.Invest. — 1996. -Vol. 98.-P. 2008−2017.
- Adiels M., Packard C., Caslake M.J. et al. A new combined multicompartmental model for apolipoprotein В 100 and triglyceride metabolism in VLDL subtractions. // J. Lipid Res. — 2005. — Vol. 46. — P. 58. — 67.
- Aitrnan T.J., Godsland I.F., Farren B. et al. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. // Arterioscler.Thromb.Vasc.Biol. 1997. — Vol. 17. — P. 748 — 754.
- Alaupovic P., Curry M., McConathy W. Quantitative determination of human plasma apolipoproteins by electroimmunoassays. // International Conference on Atherosclerosis. / ed. L. Carlson. N — Y: Raven Press, 1978.-P. 109−115.
- Allain C.C., Poon L.S., Chan C.S. et al. Enzymatic determination of total serum cholesterol. // Clin.Chem. 1974. — Vol. 20. — P. 470 — 475.
- Amri E.Z., Teboul L., Vannier C. et al. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. / // BiochemJ. 1996. — Vol. 314. — P. 541 — 546.
- Ascaso J.F., Merchante A., Lorente R.I. et al. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients. // Metabolism 1998. — Vol. 47. — P. 508 — 513.
- Avramoglu R.K., Cianflone K., Sniderman A.D. Role of the neutral lipid accessible pool in the regulation of secretion of apoB 100 lipoprotein particles by HepG2 cells. // J. Lipid Res. — 1995. — Vol. 36 — P. 2513 -2528.
- Babirak S.P., Brown B.G., Brunzell J.D. Familial combined hyperlipidemia and abnormal lipoprotein lipase. // Arterioscler.Thromb. 1992. — Vol. 12. -P. 1176−1183.
- Baldeweg S.E., Golay A., Natali A. et al. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance EGIR. // Eur.J.Clin.Invest. 2000. — Vol. 30. -P. 45 — 52.
- Baldo A., Sniderman A.D., St Luce S. et al. The adipsin — acylation stimulating protein system and regulation of intracellular triglyceride synthesis. //J.ClinJnvest. — 1993. — Vol. 92. ~ P. 1543 — 1547.
- Barter P., McPherson Y.R., Song K. et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidaemia. // J.Clin.Endocrinol.Metab. 2007. — Vol. 92. — P. 2041 — 2045.
- Bauduceau B., Baigts F., Bordier L. et al. Epidemiology of the metabolic syndrome in 2045 French military personnel EPIMIL study. // Diabetes Metab. 2005. — Vol. 31. — 4 Pt. 1 — P. 353 — 359.
- Beaumont J.L., Carlson L.A., Cooper G.R. et al. Classification of hyperlipidaemias and hyperlipoproteinaemias. // Bull. World Health Organ. 1970. — Vol. 43. -P. 891 — 915.
- Bengtsson G., Olivecrona T. Lipoprotein lipase. Mechanism of product inhibition. // Eur.J.Biochem. 1980. — Vol. 106. — P. 557 — 562.
- Bengtsson Olivecrona G., Olivecrona T. Assay of lipoprotein lipase and hepatic lipase. // Lipoprotein analysis: A practical approach. / ed. C. Converse, E. Skinner. — UK: Oxford University Press, 1992. — P. 169 — 185.
- Bhattacharya S., Dey D., Roy S.S. Molecular mechanism of insulin resistance. // J.Biosci. 2007. — Vol. 32. — P. 405 — 413.
- Bieberdorf F.A., Chernick S.S., Scow R.O. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat // J.Clin.Invest. 1970. — Vol. 49. — P. 1685 — 1693.
- Boden G., Chen X. Effects of fat on glucose uptake and utilization in patients with non insulin — dependent diabetes. // J.Clin.Invest. — 1995. -Vol. 96.-P. 1261- 1268.
- Boden G., Lebed B., Schatz M. et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. // Diabetes. 2001. — Vol. 50. — P. 1612 — 1617.
- Boden G., She P., Mozzoli M. et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor kB pathway in rat liver. // Diabetes. — 2005. — Vol. 54. — P. 3458 — 3465.
- Boden G., Shulman G. I: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta cell dysfunction. // Eur.J.Clin.Invest. — 2002. — Vol. 32. — P. 14 — 23.
- Braun J.E., Severson D.L. Regulation of the synthesis, processing and translocation of lipoprotein lipase. // Biochem.J. 1992. — Vol. 287. — P. 337−347.
- Brouwers M.C., Bilderbeek Beckers M.A., Georgieva A.M. et al. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids. // Clin.Sci. (Lond). -2007. — Vol. 112. — P. 123 — 130.
- Brown A.M., Gibbons G.F. Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. // Arterioscler.Thromb.Vasc.Biol. -2001.- Vol. 21. P. 1656−1661.
- Browning J.D., Norton J.D. Molecular mediators of hepatic steatosis and liver injury. // J.Clin.Invest. 2004. — Vol. 114. — P. 147 — 152.
- Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. // Clin.Chem. 1973. — Vol. 19. — P. 476 — 482.
- Caballeria L., Auladell M.A., Toran P. et al. Risk factors associated with non alcoholic fatty liver disease in subjects from primary care units. A case — control study. // BMC Gastroenterol. — 2008. — 8:44.
- Cahova M., Vavrinkova H., Kazdova L. Glucose — fatty acid interaction in skeletal muscle and adipose tissue in insulin resistance. // Physiol.Res. -2007.-Vol. 56.-P. 1−15.
- Camps L., Reina M., Llobera M. et al. Lipoprotein lipase in lungs, spleen, and liver: synthesis and distribution. // J. Lipid Res. 1991. — Vol. 32. — P. 1877- 1888.
- Carpentier A., Mittelman S.D., Lamarche B. et al. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. // Am.J.Physiol. 1999. -276. — P. E1055 -E1066.
- Chait A., Albers J.J., Brunzell J.D. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. // Eur.J.Clin.Invest. 1980. — Vol. 10. — P. 17 — 22.
- Charlesworth J.A., Peake P.W., Campbell L.V. et al. The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers // Int.J.Obes.Relat.Metab.Disord. 1998. Vol. 22. — P. 1096 — 1102.
- Chobanian A.V., Bakris G.L., Black H.R. et al. Seventh report of the Joint National Committee of prevention, detection, evaluation and treatment of high blood pressure. // Flypertension. 2003. — Vol.42. — P. 1206 — 1252.
- Cianflone K. The acylation stimulating protein pathway: clinical implications. // Clin.Biochem. 1997. — Vol. 30. — P. 301 — 312.
- Cianflone K., Maslowska M. Differentiation induced production of ASP in human adipocytes. // Eur.J.Clin.Invest. 1995. — Vol. 25. — P. 817 — 825.
- Cianflone K.M., Maslowska M.H., Sniderman A.D. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation -stimulating protein // J.Clin.Invest. 1990a. — Vol.85. P. 722 — 730.
- Cianflone K., Roncari D.A., Maslowska M. et al. The adipsin acylation stimulating protein in human adipocytes: Regulation of triacylglycerol synthesis. // Biochemistry. — 1994. — Vol. 33. — P. 9489 — 9495.
- Cianflone K., Vu H., Walsh M. et al. Metabolic response of acylation stimulating protein to an oral fat load. // J. Lipid Res. 1989a. — Vol. 30. -P. 1727−1733.
- Cianflone K.M., Sniderman A.D., Walsh M.J. et al. Purification and characterization of acylation stimulating protein. // J.Biol.Chem. 1989b. — Vol. 264.-P. 426−430.
- Cianflone K.M., Yasruel Z., Rodriguez M.A. et al. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. // J. Lipid Res. 1990b. -Vol. 31. — P. 2045−2055.
- Craig W.Y., Nutik R., Cooper A.D. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein. // J. Lipid Res. 1988. — Vol. 263. — P. 13 880 — 13 890.
- Crespin S.R., Greenough W.B. 3rd, Steinberg D Stimulation of insulin secretion by infusion of free fatty acids. // J.Clin.Invest. 1969. — Vol. 48. -P. 1934- 1943.
- Cui W., Paglialunga S., Kalant D. et al. Acylation stimulating protein/C5L2 — neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. // Am.J.Physiol.Endocrinol.Metab. — 2007. — Vol. 293. -P. E1482 — 1491.
- Cui W., Simaan M., Laporte S. et al. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. // Mol Immunol. 2009. — Vol. 46. — P. 3086 — 3098.
- Dixon J.L., Furukawa S., Ginsberg H.N. Oleate stimulates of apolipoprotein B — containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. // J.Biol.Chem. 1991. -Vol. 266.-P. 5080−5086.
- Dresner A., Laurent D., Marcucci M. et al. Effecrs of fatty acids on glucose transport and IRS — 1 associated phosphatidylinositol 3 — kinase activity. // J.Clin.Invest. 1999. -Vol. 103.-P. 253 -259.
- Ducharme N.A., Bickel P.E. Lipid droplets in lipogenesis and lipolysis. // Endocrinology. 2008. — Vol. 149. P. 942 — 949.
- Dyck D.J., Heigenhauser G.J., Bruce C.R. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. // Acta Physiol.Oxf. 2006. — Vol. 186. — P. 5 — 16.
- Etherton T.D. The biology of somatotropin in adipose tissue growth and nutrient partitioning. // J.Nutr. 2000. — Vol. 130. — P. 2623−2625.
- Evans K., Burdge G.C., Wootton S.A. et al. Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. // Diabetes. 2002. — Vol. 51. — P. 2684 — 2690.
- Faraj M., Cianflone K. Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP. // Am.J.Physiol.Endocrinol.Metab. 2004. — Vol. 287. — P. El50 ~ El59.
- Faraj M., Sniderman A.D., Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. // J. Lipid Res. 2004. — Vol. 45. — P. 657 — 666.
- Farese R.V. Jr., Yost T.J., Eckel R.H. Tissue — specific regulation of lipoprotein lipase activity by insulin/glucose in normal — weight human. // Metabolism. 1991. — Vol. 40. — P. 214 — 216.
- Febbraio M., Abumrad N.A., Hajjar D.P. et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. // J.Biol.Chem. 1999. — Vol. 274. — P. 19 055 — 19 062.
- Fisher E.A., Ginsberg H.N. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B containing lipoproteins. // J.Biol.Chem. — 2002. — Vol. 277. — P. 17 377 — 17 380.
- Friedevvald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. // Clin.Chem. — 1972. — Vol. 18. — P. 499 -502.
- Germinario R., Sniderman A.D., Manuel S. et al. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein.// Metabolism. — 1993. — Vol. 42. — P. 574 — 580.
- Gibbons G.F. Burnham F.J. Effect of nutritional state on the utilization of fatty acids for hepatitic triacylglycerol synthesis and secretion as very — low density lipoprotein. // Biochem.J. — 1991. — Vol. 275. — P. 87 — 92.
- Gibbons G.F., Wiggins D., Brown A.M. et al. Synthesis and function of hepatic very low — density lipoprotein. // Biochem.Soc.Trans. — 2004. -Vol. 32.-P. 59−64.
- Gilham D., Ho S., Rasouli M. et al. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. // FASEB J. 2003. — Vol. 17. — P. — 1685 — 1687.
- Ginsberg H.N. Insulin resistance and cardiovascular disease. // J.Clin.Invest. 2000. — Vol. 106. — P. 453 — 458.
- Ginsberg H.N. New perspectives on atherogenesis role of abnormal triglyceride — rich lipoprotein metabolism. // Circulation. 2002. — Vol. 106.-P. 2137−2142.
- Girard J., Perdereau D., Foufelle F. et al. Regulation of lipogenic enzyme gene expression by nutrients and hormones. // FASEB J. 1994. — Vol. 8. -P. 36−42.
- Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. // J. Lipid Res. — 1996. Vol. 37. — P. 693 -707.
- Grundy S.M., Mok H.Y., Zech L. et al. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. // J.Clin.Invest. 1979. — Vol. 63. — P. 1274 — 1283.
- Haemmerle G., Lass A., Zimmermann R. et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. // Science. 2006. — Vol. 312. — P. 734 — 737.
- Haemmerle G., Zimmermann R., Hayn M. et al. Hormone — sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. // J.Biol.Chem. 2002. — Vol. 277. — P.4806 — 4815.
- Hajduch E., Balendran A., Batty I.H. et al. Ceramide impairs the insulin -dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. // Diabetologia. 2001. -Vol. 44.-P. 173- 183.
- Hamilton J.A., Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? // Diabetes: 1999. — Vol. 48. — P. 2255 — 2269.
- Hamilton R.L., Wong J.S., Cham C.M. et al. Chylomicron sized lipid particles are formed in the setting of apolipoprotein B deficiency. // J. Lipid Res. — 1998. — Vol. 39:-P. 1543 — 1557.
- Han P., Zhang Y.Y., Lu Y. et al. Effects of different free fatty acids on insulin resistance in rats. // Hepatobiliary Pancreat.Dis.Int. 2008. — Vol. 7.-P. 91−96.
- Hanley A.J., Festa A., D’Agostino R.B. Jr. et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. // Diabetes. — 2004. — Vol. 53.-P. 1773- 1781.
- Hanley A.J., Karter A.J., Festa A. et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity. The Insulin Resistance Atherosclerosis Study. // Diabetes. 2002. — Vol. 51. — P. 2642 -2647.
- Hellerstein M.K., Christiansen M., Kaempfer S. et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. // J.Clin.Invest. -1991.-Vol. 87.-P. 1841 1852.
- Henriksson J. Influence of exercise on insulin sensitivity. // J.Cardiovasc.Risk. 1995. — Vol. 2. — P. 303 — 309.
- Hitsumoto T., Yoshinaga K., Aoyagi K. et al. Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men. // J. Atheroscler.Thromb. 2002. — Vol. 9. — P. 163 — 169.
- Hosaka K., Kikuchi T., Mitsuhida N. et al. A new colorimetric method for the determination of free fatty acids with acyl CoA synthetase and acyl -Co A oxidase. //J.Biochem. — 1981. — Vol. 89. — P. 1799−1803.
- Hotamisligil G.S. Molecular mechanisms of insulin resistance and the role of the adipocyte. // Int.J.Obes.Relat.Metab.Disord. 2000. — Vol. 24. -Suppl. 4 — P. S23-S27.
- Hua X., Yokoyama C., Wu J. et al. SREBP 2, a second basic — helix-loop-helix — leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. // Proc. Natl Acad. Sci. USA. — 1993. — Vol. 190.-P. 11 603−11 607.
- Hulver M.W., Dohm G.L. The molecular mechanism linking muscle fat accumulation to insulin resistance. // Proc.Nutr.Soc. — 2004. Vol. 63. — P. 375−380.
- Itani S.I., Ruderman N.B., Schmieder F. et al. Lipid induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB — alpha. // Diabetes. — 2002. — Vol. 51. — P. 2005−2011.
- Jazet I.M., Pijl H., Meinders A.E. Adipose tissue as an endocrine organ: impact on insulin resistance. // Neth.J.Med. 2003. — Vol. 61. — P. 194 -212.
- Jensen M.D. Adipose tissue and fatty acid' metabolism in humans. // J.R.Soc.Med. 2002. — Vol. 95. — P. 3 — 7.
- Jindrichova E., Kratochvilova S., Kovar J. Glucose administration downregulates lipoprotein lipase activity in vivo: a study using repeatedintravenous fat tolerance test. // Physiol.Res. 2007. — Vol. 56. — P. 175 -181.
- Johswich K., Martin M., Thalmann J. et al. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. // J.Biol.Chem. 2006. — Vol. 281. P. 39 088 — 39 095.
- Jong M.C., Dahlmans V.E., Hofker M.H. et al. Nascent very low -density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose — dependent manner. // Biochem.J. — 1997. — Vol. 328. — P. 745 — 750.
- Jump D.B., Botolin D., Wang Y. et al. Fatty acid regulation of hepatic gene transcription. // J.Nut. 2005. — Vol. 135. — P. 2503 — 2506.
- Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. // Exp. Clin. Endocrinol. Diabetes. 2003. — Vol. 111.-P.-246−250.
- Kakuma T., Lee Y., Higa M. et al. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. // Proc.Natl.Acad.Sci.USA. 2000. — Vol. 97. — P. 8536−8541.
- Kalant D., Cain S.A., Maslowska M. et al. The chemoattractant receptorlike protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. // J.Biol.Chem. 2003a. — Vol. 278. — P. 11 123−11 129.
- Kalant D., Maslowska M., Scantlebury T. et al. Control of lipogenesis in adipose tissue and the role of acylation stimulating protein. // Can.J.Diabetes.-2003b.-Vol. 27.-P. 154−171.
- Кафе F., Olivecrona Т., Olivecrona G. et al. Lipoprotein lipase transport in plasma: role of muscle and adipose tissues in regulation of plasma lipoprotein lipase concentration. // J. Lipid Res. 1998. — Vol. 39. — P. 2387 -2393.
- Karpe F., Olivecrona Т., Walldius G. et al. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. // J. Lipid Res. 1992. -Vol. 33.-P. 975−984.
- Kelley D.E., Mokan M., Simoneau J.A. et al. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. // J.Clin.Invest. -1993.-Vol. 92.-P. 91−98.
- Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. // EMBO. 2001. — Vol. 2. — P. 282 — 286.
- Kim J.B., Sarraf P., Wright M. et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. // J.Clin.Invest. 1998.-Vol. 101.-P. 1−9.
- Kim J.K., Fillmore J.J., Chen Y. et al. Tissue — specific overexpression of lipoprotein lipase causes tissue specific insulin resistance. // Proc.Natl.Acad.Sci.U.S.A. — 2001. — Vol. 98. — P. 7522 — 7527.
- Kissebah A.H., Alfarsi S., Adams P.W. et al. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. // Diabetologia. 1976. — Vol. 12. — P. 563 — 571.
- Knight B.L., Hebbachi A., Hauton D. et al. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. // Biochem.J. -2005. Vol. 389. — P. 413 — 421.
- Knutson V.P. The release of lipoproten lipase from 3T3 LI adipocytes is regulated by microvessel endothelial cells in an insulin — dependent manner. // Endocrinology. — 2000. — Vol. 141. — P. 693 — 701.
- Koike T., Liang J., Wang X. et al. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. // J.Biol.Chem. 2004. — Vol. 279. — P. 7521 -7529.
- Koistinen H.A., Vidal H., Karonen S.L. et al. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. //
- Kraegen E.W., Cooney G.J., Ye J.M. et al. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. // Exp.Clin.Endocrinol.Diabetes. 2001. — Vol. 109. — Suppl. 2 — P. S189-S201.
- Lagrost L., Florentin E., Guyard Dangremont V. et al. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. // Arterioscler.Thromb.Vasc.Biol. — 1995. -Vol. 15.-P. 1388- 1396.
- Lam T.K., van de Werve G., Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. // AmJ.Physiol.Endocrinol.Metab. 2003. — Vol. 284. — P. E281 -E290.
- Langin D., Dicker A., Tavernier G. et al. Adipocyte lipases and defect of lipolysis in human obesity. // Diabetes. 2005. — Vol. 54. — P. 3190 -3197.
- Laws A., Reaven G.M. Evidence for an independent relationship between insulin resistance and fasting plasma HDL cholesterol, triglyceride and insulin concentrations. // J.Intern.Med. — 1992. — Vol. 231. — P. 25 — 30.
- Levy E., Stan S., Delvin E. et al. Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons. // J.Biol.Chem. 2002. — Vol. 277. — P. 16 470 — 16 477.
- Lewis G.F. Fatty acid regulation of very low density lipoprotein production. // CuiT.Opin.Lipidol. 1997. — Vol. 8. — P. 146 — 153.
- Lewis G.F., Carpentier A., Adeli K. et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. // Endocr.Rev. 2002. — Vol. 23. — P. 201 — 229.
- Lewis G.F., Uffelman K.D., Szeto L.W. et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. // J.Clin.Invest. 1995. — Vol. 95. — P. 158 — 166.
- Lookene A., Zhang L., Hultin M. et al. Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. // J.Biol.Chem. — 2004. Vol. 279. — P. 49 964 — 49 972.
- Lopes Virella M.F., Stone P., Ellis S. et al. Cholesterol determination in high — density lipoproteins separated by three different methods. // Clin.Chem. — 1977. — Vol. 23. — P. 882 — 884.
- Lutz E.P., Merkel M., Kako Y. et al. Heparin binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.//J.Clin.Invest.-2001.-Vol. 107.-P. 1183- 1192.
- Maheux P., Azhar S., Kern P.A. et al. Relationship between insulin -mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. // Diabetologia. 1997. — Vol. 40. — P. 850 — 858.
- Mahley R.W., Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell surface heparan sulfate proteoglycans and apolipoprotein E. // J. Lipid Res. — 1999. — Vol. 40. — P. l — 16.
- Malmstrom R., Packard C.J., Watson T.D. et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. // Arterioscler.Thromb.Vasc.Biol. 1997.-Vol. 17.-P. 1454- 1464.
- Marcil M., Vu H., Cui W. et al. Identification of a novel C5L2 variant S323I in a French Canadian family with familial combined hyperlipemia. // Arterioscler.Thromb.Vasc.Biol. 2006. — Vol. 26. — P. 1619 — 1625.
- Maslowska M., Legakis H., Assadi F. et al. Targeting the signaling pathway of acylation stimulating protein. // J. Lipid Res. 2006. — Vol. 47. -P. 643−652.
- Maslowska M., Scantlebury T., Germinarlo R. et al. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. // J. Lipid Res. 1997. — Vol. 38 — P. 1 — 11.
- Maslowska M., Wang H.W., Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence // Vitam.Horm. 2005. — Vol. 70 — P. 309 — 332.
- Matthews D.R., Hosker J.P., Rudenski A.S. et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. // Diabetologia. — 1985. — Vol. 28.-P. 412−419.
- McArthur M.J., Atshaves B.P., Frolov A. et al. Cellular uptake and intracellular trafficking of long chain fatty acids. // J. Lipid Res. 1999. — Vol. 40.-P. 1371 — 1383.
- Meigs J.B., D’Agostino R.B. Sr., Wilson P.W. et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. // Diabetes. 1997. — Vol. 46. — P. 1594 — 1600.
- Meijssen S., van Dijk H., Verseyden C. et al. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. // Arterioscler.Thromb.Vasc.Biol. 2002. —Vol. 22. — P. 811−816.
- Merkel M., Eckel R.H., Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. // J. Lipid Res. 2002. — Vol. 43. — P. 1997 — 2006.
- Miller K.W., Small D.M. Structure of triglyceride rich lipoproteins an analysis of core and surface phases. // Plasma Lipoproteins / Ed. By A.M. Gotto. -N.Y.: Elsevier. — 1987. — P. 1 — 72.
- Mitchell B.D., Haffner S.M., Hazuda H.P. et al. The relation between serum insulin levels and 8 year changes in lipid, lipoprotein, and blood pressure levels // Am.J.Epidemiol. — 1992. — Vol. 136. — P. 12 — 22.
- Mostaza J.M., Vega G.L., Snell P. et al. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue. // J.Intern.Med. 1998. — Vol. 243. — P. 265 — 274.
- Murray L, Havel P.J., Sniderinan A.D. et al. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation stimulating protein. // Endocrinology. — 2000. — Vol. 141.-P. 1041- 1049.
- Murray I., Parker R.A., Kirchgessner T.G. et al. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin. // J. Lipid Res. 1997. — Vol. 38. — P. 2492 — 2501.
- Murray I., Sniderman A.D., Cianflone K. Mice lacking acylation stimulating protein ASP have delayed postprandial triglyceride clearance. // J. Lipid Res. 1999. — Vol. 40. — P. 1671 — 1676.
- Nolan C.J., Madiraju M.S., Delghingaro Augusto V. et al. Fatty acid signaling in the B — cell and insulin secretion. // Diabetes. — 2006. — Vol. 55.-Suppl.2-P. S16-S23.
- Oh R.C., Lanier J.B. Management of hypertriglyceridemia. // Am.Fam.Physician. 2007. — Vol. 75. — P. — 1365 — 1371.
- Okazaki H., Igarashi M., Nishi M. et al. Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol. // Diabetes. -2006. Vol. 55. — P. 2091 — 2097.
- Olivecrona T., Bengtsson Olivecrona G. Lipoprotein lipase and hepatic lipase // Curr.Opin.Lipidol. — 1993. — Vol. 4. — P. 187 — 196.
- Olivecrona T., Chernick S.S., Bengtsson Olivecrona G. et al. Synthesis and secretion of lipoprotein lipase in 3T3 — LI adipocytes. Demonstration of inactive forms of lipase in cells. // J.Biol.Chem. — 1987. — Vol. 262. — P. 10 748−10 759.
- Ong J.M., Kirchgessner T.G., Schotz M.C. et al. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. //J.Biol.Chem. 1988. — Vol. 263. — P. 12 933 — 12 938.
- Oprescu A.I., Bikopoulos G., Naassan A. et al. Free fatty acid induced reduction in glucose — stimulated insulin secretion. // Diabetes. — 2007. -Vol. 56.-P. 2927−2937.
- Packard C.J., Demant T., Stewart J.P. et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. // J. Lipid Res. 2000. -Vol. 41.-P. 305−318.
- Paglialunga S., Fisette A., Yan Y. et al. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.// Am.J.Physiol.Endocrinol.Metab. 2008. — Vol. 294. — P. E521 -E529.
- Paglialunga S., Schrauwen P., Roy C. et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. // J.Endocrinol. 2007. — Vol. 194. — P. 293 — 304.
- Pankow J.S., Duncan B.B., Schmidt M.I. et al. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. // Diabetes Care. 2004. — Vol. 27. — P. 77 — 82.
- Parhofer K.G., Barrett P.H. Thematic review series: patient oriented research. What we have learned about VLDL and LDL metabolism from human kinetics studies. // J. Lipid Res. — 2006. — Vol. 47. — P. 1620 — 1630.
- Parks E.J., Hellerstein M.K. Thematic review series: patient oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques. // J. Lipid Res. — 2006. — Vol. 47. -P. 1651−1660.
- Patsch W., Tamai T., Schonfeld G. Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures. // J.Clin.Invest. 1983. — Vol. 72. — P. 371 — 378.
- Peiris A.N., Hennes M.I., Evans D.J. et al. Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. // Acta Med.Scand.Suppl. 1988. — Vol. 723. — P. 179−188.
- Pejic R.N., Lee D.T. Hypertriglyceridemia. // J.Am.Board.Fam.Med. -2006.-Vol. 19.-P. 310−316.
- Pennacchio L.A., Olivier M., Hubacek J.A. et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. // Hum.Mol.Genet. 2002. — Vol. 11. P. 3031 — 3038.
- Petersen K.F., Dufour S., Befroy D. et al. Impaired mitochondrial activity in the insulin resistant offspring of patients with type 2 diabetes. // N.Engl.J.Med. — 2004. — Vol. 350. — P. 664 — 671.
- Peterson J., Bihain B.E., Bengtsson Olivecrona G. et al. Fatty acid control of lipoprotein lipase: A link between energy metabolism and lipid transport. // Proc .Natl .Acad. S ci. USA. — 1990. — Vol. 87. — P. 909 — 913.
- Pickersgill L., Litherland G.J., Greenberg A.S. et al. Key role for ceramides in mediating insulin resistance in human muscle cells. // J.Biol.Chem. -2007. Vol. 282. — P. 12 583 — 12 589.
- Pont F., Duvillard L., Florentin E. et al. Early kinetic abnormalities of apoB — containing lipoproteins in insulin — resistant women with abdominal obesity. // Arterioscler.Thromb.Vasc.Biol. 2002. — Vol. 22. — P. 1726 -1732.
- Postic C., Dentin R., Denechaud P.D. et al. ChREBP, a transcriptional regulator of glucose and lipid metabolism. / C. Postic et al. // Annu.Rev.Nutr. 2007. — Vol. 27. — P. 179 — 192.
- Pouliot M.C., Despres J.P., Nadeau A. et al. Associations between regional body fat distribution, fasting plasma free fatty acid levels and glucose tolerance in premenopausal women. // Int.J.Obes. 1990. — Vol. 14. — P. 293 — 302.
- Raabe M., Veniant M.M., Sullivan M.A. et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue — specific knockout mice. // J.Clin.Invest. 1999. — Vol. 103. — P. 1287 — 1298.
- Robinson D.S. The function of the plasma triglycerides in fatty acid transport. // Comprehensive Biochemistry / Ed. by M. Florkin and E. H. Stotz. Amsterdam: Elsevier. — 1970. — P. 51 — 105.
- Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. // Clin.Endocrinol. (Oxf.) 2006. — Vol. 64. — P. 355 -365.
- Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. // Nature. 2006. — Vol. 444. — P. 847 — 853.
- Sako Y. Grill V.E. A 48 hour lipid infusion in the rat time — dependency inhibits glucose — induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. // Endocrinology. — 1990. -Vol. 127.-P. 1580- 1589.
- Saleh J., Summers L.K., Cianflone K. et al. Coordinated release of acylation stimulating protein ASP and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. // J. Lipid Res. — 1998. -Vol. 39.-P. 884−891.
- Salinari S., Bertuzzi A., Manco M. et al. NEFA — glucose comodulation model of 3—cell insulin secretion in 24 h multiple — meal test. // Am.J.Physiol.Endocrinol.Metab. — 2007. — Vol. 292. — P. El 890 — E1898.
- Savage D.B., Petersen K.F., Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. // Physiol.Rev. — 2007. — Vol. 87. -P. 507−520.
- Saxena U., Klein M.G., Goldberg I.J. Metabolism of endothelial cell -bound lipoprotein lipase. Evidence for heparan sulfate proteoglycanmediated internalization and recycling. I I J.Biol.Chem. — 1990. Vol. 265. -P. 12 880- 12 886.
- Saxena U., Klein M.G., Goldberg I.J. Transport of lipoprotein lipase across endothelial cells. // Proc.Natl.Acad.Sci.USA. 1991. — Vol. 88. — P.2254 -2258.
- Saxena U., Witte L.D., Goldberg I.J. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. // J.Biol.Chem. 1989. -Vol. 264.-P. 4349−4355.
- Schonfeld G., Patterson B.W., Yablonskiy D.A. et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. // J. Lipid Res. 2003. — Vol. 44. -P. 470−478.
- Schreier L., Berg G., Zago V. et al. Kinetics of in vitro lipolysis of human very low density lipoprotein by lipoprotein lipase. // Nutr.Metab.Cardiovasc.Dis. — 2002. — Vol. 12. — P. 13 — 18.
- Schweiger M., Schreiber R., Haemmerle G. et al. Adipose triglyceride lipase and hormone sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. // J.Biol.Chem. — 2006. — Vol. 281. — P. 40 236−40 241.
- Seda O. Comparative gene map of hypertriglyceridaemia. // Folia Biol.Praha. 2004. — Vol. 50. — P. 43 — 57.
- Shafrir E., Raz I. Diabetes: mellitus or lipidus? // Diabetologia. 2003. -Vol. 46.-P. 433−440.
- Shoulders C.C., Jones E.L., Naoumova R.P. Genetics of familial combined hyperlipidemia and risk of coronary heart disease. // Hum.Mol.Genet. — 2004.-Vol. 13. P. R149 — R160.
- Smith U. Impaired 'diabetic' insulin signaling and action occur in fat cellslong before glucose intolerance--is insulin resistance initiated in theadipose tissue? // Int.J.Obes.Relat.Metab.Disord. 2002. — Vol. 26. — P. 897−904.
- Soni K.G., Lehner R, Metalnikov P. et al. Carboxylesterase 3 EC 3.1.1.1 is a major mdipocyte lipase. // J.Biol.Chem. 2004. — Vol. 279. — P. 40 683 -40 689.
- Soro A., Jauhiainen M., Ehnholm C. et al. Determinants of low HDL levels in familial combined hyperlipidemia. // J. Lipid Res. 2003. — Vol. 44. — P. 1536- 1544.
- Steinberg G.R. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. // Cell Cycle. -2007.-Vol. 6.-P. 888−894.
- Steiner G., Lewis G.F. Hyperinsulinemia and triglyceride rich lipoproteins. // Diabetes. — 1996. — Vol. 45. — Suppl. 3 — P. S24 — S26.
- Sumner A.E., Finley K.B., Genovese D.J. et al. Fasting triglyceride and the triglyceride HDL cholesterol ratio are not markers of insulin resistance in African Americans. // Arch.Intern.Med. — 2005. — Vol. 165. — P. 1395 -1400.
- Teruel T., Hernandez R., Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor — alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. // Diabetes. 2001. — Vol. 50. — P. 2563−2571.
- Tirosh A., Shai 1., Bitzur R. et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. // Diabetes Care. 2008. — Vol. 31.-P. 2032−2037.
- Trickett J.I., Patel D.D., Knight B.L. et al. Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation. // J.Biol.Chem. 2001. — Vol. 276. -P. 39 522−39 532.
- Vessby B., Boberg J., Lithell H. Lipolytic activities in post heparin plasma in man measured with different substrate emulsions. // Clin.Sci.Mol.Med. — 1978. — Vol. 54. — P. 201 — 203.
- Vilaro S., Llobera M., Bengtsson Olivecrona G. et al. Lipoprotein lipase uptake by the liver: localization, turnover, and metabolic role. // Am.J.Physiol. — 1988. — Vol. 254. (5 Pt 1) — P. G711 — G722.
- Vilella E., Joven J., Fernandez M. et al. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol rich lipoproteins. // J. Lipid Res. — 1993. — Vol. 34. — P. 1555 — 1564.
- Wang M.Y., Lee Y., Unger R.H. Novel form of lipolysis induced by leptin. //J.Biol.Chem. 1999. — Vol. 274. — P. 17 541−17 544.
- Ward P.A. Functions of C5a receptors. // J.Mol.Med. 2009. — Vol. 87. -P. 375−378.
- Wetsel R.A., Kildsgaard J., Zsigmond E. et al. Genetic deficiency of acylation stimulating protein (ASP (C3ades Arg)) does not cause hyperapobetalipoproteinemia in mice. // J.Biol.Chem. — 1999. — Vol. 274. -P. 19 429−19 433.
- Wong H., Davis R.C., Thuren T. et al. Lipoprotein lipase domain function. // J.Biol.Chem. 1994. — Vol. 269. — P. 10 319 — 10 323.
- Wu X., Shang A., Jiang H. et al. Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a «secretion coupled» pool. // J. Lipid Res. — 1996. — Vol. 37. — P. 1198 -1206.
- Xia Z., Sniderman A.D., Cianflone K. Acylation — stimulating protein ASP deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. // J.Biol.Chem. 2002. — Vol. 277. — P. 45 874 — 45 879.
- Ylitalo K., Pajukanta P., Meri S. et al. Serum C3 but not plasma acylation -stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. // Arterioscler.Thromb.Vasc.Biol. 2001. — Vol. 21. — P. 838 — 843.
- Yoshii H., Lam T.K., Gupta N. et al. Effects of portal the free fatty acid elevation on insulin clearance and hepatic glucose flux. // Am.J.Physiol.Endocrinol.Metab. 2006. — Vol. 290. — P. E1089 — E1097.
- Yu Y.H., Ginsberg H.N. Adipocyte signaling and lipid' homeostasis: sequelae of insulin resistant adipose tissue. // Cir.Res. — 2005. — Vol. 96. -P. 1042- 1052.
- Zhang X.J., Cianflone K., Genest J. et al. Plasma acylation stimulating protein ASP as a predictor of impaired cellular biological response to ASP in patients with hyperapoB. // Eur.J.Clin.Invest. 1998. — Vol. 28. — P. 730 -739.
- Zimmermann R., Strauss J.G., Haemmerle G. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. // Science. -2004.-Vol. 306.-P. 1383 1386.